Literature DB >> 10344215

Links between genetic and environmental factors and prostate cancer risk.

P Ekman1, H Grönberg, H Matsuyama, M Kivineva, U S Bergerheim, C Li.   

Abstract

BACKGROUND: Genetic polymorphisms and expression of steroid receptors may explain why some individuals are more at risk of developing prostate cancer. Some risk factors often discussed are androgen stimulation, and vitamin A and D deficiency. Long CAG-repeats in exon 1 of the androgen receptor (AR) gene on the X chromosome seem to have a protective role against androgen overstimulation. Likewise, long vitamin D receptor alleles in the poly-A tract may prevent vitamin D stimulation.
METHODS: Blood samples from 59 Swedish patients with sporadic prostate cancers, 59 with hereditary prostate cancer, and 34 Japanese prostate cancer patients were compared with benign controls. Tissue specimens from 37 Swedish and 23 Japanese prostate cancer patients with matching blood samples were investigated by immunohistochemical techniques.
RESULTS: The number of CAG-repeats was identical in sporadic and hereditary prostate cancer patients, but the repeats were significantly shorter than in benign controls. Benign Japanese controls were similar to Swedish controls, but Japanese prostate cancers had longer repeats than did controls. Both the vitamin D and A receptor staining was stronger in Japanese than in Swedish prostate cancer specimens. Prostate cancer occurs approximately 5 years later in Japanese compared with Swedish men.
CONCLUSIONS: Varying lengths of CAG-repeats of the androgen receptor cannot fully explain racial differences in clinical prostate cancer incidence. A larger content of vitamin A and D receptors may be linked to a delayed onset of clinical prostate cancer in Japanese men.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10344215     DOI: 10.1002/(sici)1097-0045(19990601)39:4<262::aid-pros6>3.0.co;2-p

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study.

Authors:  Matthew L Freedman; Celeste L Pearce; Kathryn L Penney; Joel N Hirschhorn; Laurence N Kolonel; Brian E Henderson; David Altshuler
Journal:  Am J Hum Genet       Date:  2004-11-29       Impact factor: 11.025

2.  A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors:  David G Cox; Hélène Blanché; Celeste L Pearce; Eugenia E Calle; Graham A Colditz; Malcolm C Pike; Demetrius Albanes; Naomi E Allen; Pilar Amiano; Goran Berglund; Heiner Boeing; Julie Buring; Noel Burtt; Federico Canzian; Stephen Chanock; Françoise Clavel-Chapelon; Heather Spencer Feigelson; Matthew Freedman; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Robert Hoover; David J Hunter; Rudolf Kaaks; Laurence Kolonel; Peter Kraft; Loic LeMarchand; Eiliv Lund; Domenico Palli; Petra H M Peeters; Elio Riboli; Daniel O Stram; Michael Thun; Anne Tjonneland; Dimitrios Trichopoulos; Meredith Yeager
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

Review 3.  Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis.

Authors:  Zhiqiang Qin; Xiao Li; Peng Han; Yuxiao Zheng; Hanyu Liu; Jingyuan Tang; Chengdi Yang; Jianzhong Zhang; Kunpeng Wang; Xiaokang Qi; Min Tang; Wei Wang; Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 4.  The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer.

Authors:  Elizabeth O Lillie; Leslie Bernstein; Giske Ursin
Journal:  Breast Cancer Res       Date:  2003-04-02       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.